483
Banco Vida Corp.Banco Vida Corp. – FDA 483, Sep 18, 2019
Record Details
Banco Vida Corp. in San Juan, PR, received a Form 483 with four observations related to deficiencies in donor screening and testing for human cells, tissues, and cellular and tissue-based products (HCT/Ps). The firm failed to adequately screen donors for communicable disease risk factors, including ZIKV and Creutzfeldt-Jacob Disease (CJD), and lacked proper procedures for donor eligibility determination. Additionally, the firm used an uncleared test for syphilis screening.
View Company Profile
ID · e1632579-f12c-43e0-9526-55c89ccc4ede
Other documents for Banco Vida Corp.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.